Elevance Health, Inc. (LON:0HG8)

Market Cap	56.01B -24.1%
Revenue (ttm)	147.95B +12.6%
Net Income	4.21B -5.3%
EPS	18.73 -1.8%
Shares Out	n/a
PE Ratio	13.31
Forward PE	13.41
Dividend	5.14 (1.49%)
Ex-Dividend Date	Dec 5, 2025

Volume	120
Average Volume	1,038
Open	344.65
Previous Close	343.99
Day's Range	330.86 - 350.31
52-Week Range	273.50 - 458.75
Beta	0.52
RSI	43.02
Earnings Date	Jan 28, 2026

About Elevance Health

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2001
• Employees: 104,200
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0HG8

Financial Performance

In 2025, Elevance Health's revenue was $199.13 billion, an increase of 12.62% compared to the previous year's $176.81 billion. Earnings were $5.66 billion, a decrease of -5.32%.

Financial numbers in USD